The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment
Open Access
- 5 September 2013
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 122 (10) , 1707-1711
Abstract
Although activation of tyrosine kinase pathways is a shared theme among myeloproliferative neoplasms, the pathogenetic basis of chronic neutrophilic leukemia (CNL) has remained elusive. Recently, we identified high-frequency oncogenic mutations in the granulocyte-colony stimulating factor receptor (CSF3R) in CNL and in some patients with atypical chronic myeloid leukemia. Inhibition of Janus kinase 2 or SRC kinase signaling downstream of mutated CSF3R is feasible and should be explored therapeutically. Herein, we discuss the potential impact of these findings for the classification and treatment of these disorders.Keywords
This publication has 32 references indexed in Scilit:
- OncogenicCSF3RMutations in Chronic Neutrophilic Leukemia and Atypical CMLNew England Journal of Medicine, 2013
- SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMMLLeukemia, 2013
- Presence of the JAK2 V617F Mutation in a Patient with Chronic Neutrophilic Leukemia and Effective Response to Interferon Alfa-2bActa Haematologica, 2013
- SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemiasLeukemia, 2013
- Recurrent SETBP1 mutations in atypical chronic myeloid leukemiaNature Genetics, 2012
- The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both “atypical” myeloproliferative disorders and myelodysplastic syndromesBlood, 2005
- WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literatureLeukemia, 2004
- Granulocyte Colony Stimulating Factor-Producing Multiple Myeloma Associated with NeutrophiliaLeukemia & Lymphoma, 2004
- CHRONIC NEUTROPHILIC LEUKAEMIA: A DISTINCT CLINICAL ENTITY?British Journal of Haematology, 2002
- Impaired Production and Increased Apoptosis of Neutrophils in Granulocyte Colony-Stimulating Factor Receptor–Deficient MiceImmunity, 1996